KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Accumulated Depreciation & Amortization (2018 - 2025)

Twist Bioscience (TWST) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 2.92% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, down 2.92% year-over-year, with the annual reading at $24.9 million for FY2025, 20.93% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $6.2 million at Twist Bioscience, down from $24.9 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $31.4 million in Q3 2024, with the low at $3.2 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $14.8 million, with a median of $12.6 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 79.99% in 2023, then decreased 23.92% in 2025.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $3.2 million in 2021, then skyrocketed by 68.0% to $5.3 million in 2022, then surged by 54.4% to $8.2 million in 2023, then fell by 21.92% to $6.4 million in 2024, then decreased by 2.92% to $6.2 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $6.2 million, $24.9 million, and $18.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.